Share-based Payment Arrangement, Expense in USD of 2seventy bio, Inc. from 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
2seventy bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2019 to Q1 2025.
  • 2seventy bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $2.23M, a 52.5% decline year-over-year.
  • 2seventy bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $9.69M, a 64.3% decline year-over-year.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12.2M, a 62.2% decline from 2023.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $32.2M, a 21.6% decline from 2022.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $41M, a 24.9% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

2seventy bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $9.69M $2.23M -$2.46M -52.5% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $12.2M $2.44M -$2.52M -50.8% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025
Q3 2024 $14.7M $2.64M -$7.16M -73% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $21.8M $2.39M -$5.36M -69.2% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $27.2M $4.68M -$4.98M -51.5% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 $32.2M $4.95M -$4.45M -47.3% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025
Q3 2023 $36.6M $9.8M -$2.41M -19.7% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $39M $7.74M -$1.95M -20.1% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $41M $9.67M -$73K -0.75% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $41M $9.41M -$4.92M -34.3% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024
Q3 2022 $46M $12.2M +$977K +8.7% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $45M $9.69M -$2.28M -19% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $47.3M $9.74M -$7.37M -43.1% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $54.6M $14.3M 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2024
Q3 2021 $11.2M -$4.03M -26.4% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $12M 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $17.1M 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 $15.3M 01 Jul 2020 30 Sep 2020 10-Q 01 Dec 2021

2seventy bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.2M -$20M -62.2% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025
2023 $32.2M -$8.88M -21.6% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025
2022 $41M -$13.6M -24.9% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024
2021 $54.6M -$6.37M -10.4% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2024
2020 $61M -$1.05M -1.7% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023
2019 $62M 01 Jan 2019 31 Dec 2019 10-K 22 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.